Clinical Trial Update: Phase II Study of "VIPER" Chemotherapy in Rel/Ref DLBCL [Phase 2]

View source ↗

Summary

Phase II trial results for the VIPER chemotherapy regimen in relapsed/refractory diffuse large B-cell lymphoma (a form of non-Hodgkin lymphoma). The study is co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma
• Non-hodgkin Lymphoma

Drugs mentioned

• Etoposide (Etoposide)
• IFOSFAMIDE (IFOSFAMIDE)
• Rituximab (rituximab)
• Vincristine (vincristine)

Snippet

Sponsor: Weill Medical College of Cornell University | Conditions: Non-Hodgkin's Lymphoma | Phase 2 | Status: COMPLETED | Results posted: 2017-04-07